Sfe Investment Counsel Pfizer Inc Transaction History

Sfe Investment Counsel

$598 Million
Q3 2025

A detailed history of Sfe Investment Counsel transactions in Pfizer Inc stock. As of the latest transaction made, Sfe Investment Counsel holds 70,300 shares of PFE stock, worth $1.76 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

70,300

Previous 75,230 6.55%

Holding current value

$1.76 Million

Previous $1.82 Million 1.76%

% of portfolio

0.3%

Previous 0.34%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$23.29 - $25.88 $114,819 - $127,588	-4,930 Reduced 6.55%	70,300 $1.79 Million
Q2 2025 Aug 07, 2025	BUY	$21.59 - $24.84 $82,301 - $94,690	3,812 Added 5.34%	75,230 $1.82 Million
Q1 2025 May 06, 2025	BUY	$25.01 - $27.13 $277,310 - $300,817	11,088 Added 18.38%	71,418 $1.81 Million
Q4 2024 Jan 29, 2025	SELL	$24.8 - $30.19 $712,628 - $867,509	-28,735 Reduced 32.26%	60,330 $1.6 Million
Q3 2024 Oct 24, 2024	SELL	$27.7 - $31.39 $152,737 - $173,084	-5,514 Reduced 5.83%	89,065 $2.58 Million

Q2 2024 Aug 05, 2024	SELL	$25.26 - $29.6 $184,271 - $215,932	-7,295 Reduced 7.16%	94,579 $2.65 Million
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $589,515 - $676,952	22,770 Added 28.78%	101,874 $2.83 Million
Q4 2023 Jan 31, 2024	SELL	$26.13 - $33.94 $1.26 Million - $1.63 Million	-48,165 Reduced 37.85%	79,104 $2.28 Million
Q3 2023 Oct 24, 2023	BUY	$32.09 - $37.51 $226,715 - $265,008	7,065 Added 5.88%	127,269 $4.22 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $164,165 - $189,935	4,545 Added 3.93%	120,204 $4.41 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $557,762 - $726,124	14,160 Added 13.95%	115,659 $4.72 Million
Q4 2022 Feb 09, 2023	SELL	$41.75 - $54.5 $95,440 - $124,587	-2,286 Reduced 2.2%	101,499 $5.2 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $14,440 - $17,628	-330 Reduced 0.32%	103,785 $4.54 Million
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $37,921 - $44,963	815 Added 0.79%	104,115 $5.46 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $86,833 - $107,597	-1,898 Reduced 1.8%	103,300 $5.35 Million
Q4 2021 Feb 07, 2022	SELL	$41.32 - $61.25 $174,370 - $258,475	-4,220 Reduced 3.86%	105,198 $6.21 Million
Q3 2021 Nov 12, 2021	SELL	$39.25 - $50.42 $50,436 - $64,789	-1,285 Reduced 1.16%	109,418 $4.71 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $344,376 - $390,121	9,590 Added 9.48%	110,703 $4.34 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $1.56 Million - $1.76 Million	46,687 Added 85.78%	101,113 $3.66 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $457,668 - $581,965	13,674 Added 33.55%	54,426 $2 Million
Q3 2020 Nov 09, 2020	BUY	$31.75 - $37.25 $297,148 - $348,622	9,359 Added 29.81%	40,752 $1.5 Million
Q2 2020 Aug 05, 2020	BUY	$30.12 - $36.54 $203,852 - $247,302	6,768 Added 27.48%	31,393 $1.03 Million
Q1 2020 May 04, 2020	BUY	$27.03 - $38.62 $1,351 - $1,930	50 Added 0.2%	24,625 $804,000
Q4 2019 Jan 17, 2020	SELL	$32.92 - $37.36 $85,098 - $96,575	-2,585 Reduced 9.52%	24,575 $963,000
Q3 2019 Oct 31, 2019	BUY	$32.49 - $42.13 $23,880 - $30,965	735 Added 2.78%	27,160 $976,000
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $42,562 - $46,762	-1,135 Reduced 4.12%	26,425 $1.12 Million
Q4 2018 Feb 07, 2019	SELL	$38.47 - $43.86 $439,750 - $501,363	-11,431 Reduced 29.32%	27,560 $1.2 Million
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $8,755 - $10,619	-254 Reduced 0.65%	38,991 $1.72 Million
Q2 2018 Jul 30, 2018	SELL	$32.98 - $35.16 $9,432 - $10,055	-286 Reduced 0.72%	39,245 $1.42 Million
Q1 2018 May 01, 2018	SELL	$31.91 - $37.02 $140,404 - $162,888	-4,400 Reduced 10.02%	39,531 $1.4 Million
Q4 2017 Feb 06, 2018	SELL	$33.26 - $35.29 $7,816 - $8,293	-235 Reduced 0.53%	43,931 $1.59 Million
Q3 2017 Nov 01, 2017	BUY	$31.0 - $34.15 $1.37 Million - $1.51 Million	44,166	44,166 $1.58 Million

Others Institutions Holding PFE

# of Institutions

3,357

Shares Held

3.57B

Call Options Held

86.1M

Put Options Held

105M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $141B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sfe Investment Counsel, based on Form 13F filings with the SEC.

News

Stay updated on Sfe Investment Counsel with notifications on news.

Account

Sfe Investment Counsel Pfizer Inc Transaction History